Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AACR, accommodate, allograft, anti, appendageal, bolster, bone, breakthrough, card, catastrophic, Chairman, Chinese, chronic, clause, Clawback, CMC, coincide, comprising, congenital, coordinate, CRO, CRR, cutoff, deprioritization, Dieter, disaggregation, dissolution, DOR, drew, DSCSA, EMILY, equitable, Esposito, exact, expert, fast, fatigue, fifteen, FrontRunner, HILL, hybrid, hypotension, inadvertently, Inctye, Incyte, India, inhibitor, input, instant, intraocular, irreversible, join, led, lifecycle, lymphoma, malignancy, median, melanocytoma, mental, metastasize, Mexico, mobile, morbidity, mortality, multiplied, neoadjuvant, Nevada, ninety, Notably, ocular, oral, Pamela, paradigm, password, penetration, phishing, Plenary, posture, predisposition, predominant, promptly, PSU, pyrexia, quantify, ramp, rarity, RECIST, redistributed, regular, reinitiating, runway, sequence, Session, software, staying, step, subtracting, sudden, surrogate, syndrome, Tanya, thirty, threshold, Title, truthful, UM, UMs, unchanged, unethical, unresectable, VP, Washington, Weinand, withheld
Filing tables
Filing exhibits
- 10-K Annual report
- 4.3 EX-4.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.33 EX-10.33
- 10.34 EX-10.34
- 10.35 EX-10.35
- 10.36 EX-10.36
- 10.39 EX-10.39
- 10.40 EX-10.40
- 10.41 EX-10.41
- 10.42 EX-10.42
- 10.43 EX-10.43
- 21.1 EX-21.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Related press release
REPL similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-265805) and Form S-8 (Nos. 333-226323, 333-256314 and 333-272031) of Replimune Group, Inc. of our report dated May 16, 2024 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
May 16, 2024